AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06690892 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ready-to-eat beef in frozen, 5-oz packages
Description: The dietary intervention lasts 12 weeks for each individual. Participants in the experimental group will receive this intervention. Each participant will acquire 5 portions of ready-to eat beef in frozen packages per week (1 portion of sirloin cap steak strips, 1 portion of shredded chuck roast, 1 portion of petite shoulder medallions, and 2 portions of ground beef crumbles); each portion of ready-to-eat beef in this intervention will weigh 5 ounces.
Study NCT06690892 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Ready-to-eat beef in frozen, 1-oz packages
Description: The dietary intervention lasts 12 weeks for each individual. Participants in the control group will receive this intervention. Each participant will acquire 5 portions of ready-to eat beef in frozen packages per week (1 portion of sirloin cap steak strips, 1 portion of shredded chuck roast, 1 portion of petite shoulder medallions, and 2 portions of ground beef crumbles); each portion of ready-to-eat beef in this intervention will weigh 1 ounces.
Study NCT06689787 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-Guided STAIR Coach with Real-Time Assessment
Description: Two mobile apps to be used as one intervention package to support participants in their progress through STAIR (Skills Training in Affective and Interpersonal Regulation) with self-monitoring of symptoms and functioning
Study NCT06689787 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Real-Time Assessment
Description: One mobile app to support participants in self-monitoring of symptoms and functioning
Study NCT06690632 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: water preparation
Description: ingestion of 1.5L of water 30min prior MRE acquisition
Study NCT06690632 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: polyethylene glycol preparation
Description: ingestion of 1.5L of water diluted PEG 45 min prior MRE acquisition (standard protocol)
Study NCT06687005 — intervention group
Intervention type: PROCEDURE
Intervention: non-surgical periodontal therapy
Description: non-surgical periodontal therapy
Study NCT06691633 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Preoperative Methadone
Description: patient receives a one-time preoperative dose of 10 mg of methadone
Study NCT06691633 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative Oxycodone
Description: patient receives a one-time preoperative dose of 10 mg of oral oxycodone
Study NCT06695884 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: TMS will be delivered using a robotic neuronavigation system (Smartmove, ANT). Stimulation intensity will be standardized. Stimulation will be delivered to the L-DLPFC using a active/placebo figure-8 coil and a magventure TMS device.
Study NCT06687941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AST-201
Description: AST-201 is administered intravenously on Days 1, 8, and 15 of each 28-day cycle, followed by a one-week rest period. Dosing is repeated until DLT or disease progression is occurred.
Study NCT06687707 — intervention group
Intervention type: OTHER
Intervention: Attitude Scale towards Physiotherapy Profession
Description: It is a questionnaire that evaluates the attitudes of physiotherapists with 35 questions under 3 headings: professional satisfaction, qualifications required by the profession, and concerns about the profession. It was developed in 2018 by Begümhan Turhan. In this scale, which is a Likert-type questionnaire, each question is scored between 0 and 5 points. The minimum score that can be obtained from the scale is 35 and the maximum score is 175. A high score indicates that physiotherapists have a positive attitude towards their profession
Study NCT06687707 — intervention group
Intervention type: OTHER
Intervention: Minnesota Job Satisfaction Scale
Description: It is a 20-item Likert-type questionnaire. Scores less than 3 points indicate low job satisfaction. Turkish validity and reliability studies were conducted. The validity and reliability study in Turkey was conducted by Baycan and the Cronbach's alpha value of the scale was found to be 0.77. It is a tool consisting of 20 items with features that reveal internal and external job satisfaction factors. The neutral satisfaction score of the scale is 3. If the score obtained from the scale is less than 3, job satisfaction is considered low, and if it is greater than 3, job satisfaction is considered high.
Study NCT06687707 — intervention group
Intervention type: OTHER
Intervention: Maslach Burnout Scale
Description: The Burnout Inventory, which was developed by Maslach and Jackson (1981) and introduced to the literature under Maslach's name, is a seven-point Likert-type scale and consists of a total of 22 items and three subscales. Among these subscales, emotional exhaustion subscale consists of 9 items, depersonalisation subscale consists of 5 items and personal accomplishment subscale consists of 8 items. Scale items are scored as '1 never' and '7 always'. The Turkish validity and reliability of the questionnaire was conducted by Burhan Çapri. It is a 5-point Likert-type scale measured with 0: never 4: always options. High scores are expected
Study NCT06368193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuralert Monitor
Description: Device to identify upper extremity asymmetry in patients who are high risk for stroke.
Study NCT06359626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YHP2205
Description: Test drug: YHP2205
Study NCT06359626 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YHR2401
Description: comparator: YHR2401
Study NCT06694350 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab+Flutamide
Description: Pembrolizumab 200mg ivgtt once +Flutamide 250mg，Q8h
Study NCT05339659 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: mHealth Intervention
Description: Mobile health (mHealth) app to motivate and support quitting smoking.
Study NCT05339659 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mHealth Intervention
Description: Mobile health (mHealth) app to motivate and support quitting smoking.
Study NCT05272176 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping Long Term with Active Suicide Program (CLASP)
Description: Telehealth-based case management intervention designed to reduce suicidal behavior among individuals at high risk for suicide across the transition from inpatient hospitalization to the community.
Study NCT05478213 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Monophasic Action Potential (MAP) Catheter
Description: The EasyMap catheter is a temporary quadripolar catheter for recording monophasic action potentials and for intracardiac pacing. During a standard of care VT ablation, the MAP catheter will be used to study cellular action potential of the ventricular myocardium, which cannot be done on traditional catheters. The catheter is placed on the myocardium (similar to other traditional catheters) and a recording signal is transmitted to the workstation. Using the MAP catheter the will not interrupt or distort any of the standard treatment procedures.
Study NCT04619147 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is descriptive, retrospective study to evaluate the epidemiology of invasive fungal infections (IFI) in patients undergoing allogeneic haematopoiectic stem cell transplant in the era of antifungal prophylaxis with posaconazole delay-released tablets.
Study NCT06542289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BlinkER device.
Description: Participants will use the BlinkER System for 8-16 hours daily (removed during sleep) at approximately 10 blinks/minute. The stimulation cycle will be ON and OFF to achieve the desired blink rate. Participants will receive training on device usage before starting the study.
Study NCT06055569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rehabilitation protocol: AOT+NMES
Description: Action observation and neuromuscular electrical stimulation followed by motor execution
Study NCT06055569 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation protocol: Action Observation Therapy (AOT)
Description: Action observation followed by motor execution
Study NCT06055569 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Observation of motor-neutral stimuli (MNO)
Description: Motor-neutral observation followed by motor execution
Study NCT05893030 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: anesthesia guided by sedation and analgesia monitoring
Description: Anesthesia guided by sedation and analgesia monitoring The level of sedation will be monitored by~* Monitoring System BIS™ : Bispectral index (BIS) between 45 and 60 AND Suppression Ratio (SR) at 0;~* or SedLine® Sedation Monitor : Patient State Index (PSi) between 25 and 50;~* or Entropy Sensor™: State entropy (SE) between 45 and 60 AND Burst Suppression Ratio (BSR) at 0;~and the level of nociception by :~* Nociception monitor PMD-200® : Nociception Level (NoL) between 10 and 25.
Study NCT05893030 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: anesthesia performed according only to the clinical judgment of the anesthetist as usual practice
Description: Administration of anesthesia will be performed according to the clinical judgment of the anesthetist as usual practice without sedation and analgesia monitoring
Study NCT04818177 — intervention group
Intervention type: DRUG
Intervention: Institutional standard intravenous immune globulin treatment
Description: No treatments will be prospectively assigned. Subjects will receive their standard intravenous immune globulin doses. We will measure body composition and identify the relationship between body composition and intravenous immune globulin disposition.
Study NCT06421285 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Aerobic exercise, Strength training, Flexibility exercise
Description: Aerobic exercise: 30-40 minutes/time, 3-5 times a week, intensity of 4-6 points on the Rating of Perceived Exertion(RPE) 10-point scale(A simple conversation is possible during exercise, but the intensity is such that you feel out of breath) Strength training: 2-3 times a week, 3 sets of 10 repetitions per movement~* Upper extremities: Biceps brachii, triceps brachii, deltoid, pectoralis muscle exercise~* Lower extremities: gluteus maximus, hamstrings, quadriceps exercise Flexibility exercise: Stretching and mobility exercises reflecting post-surgery rehabilitation
Study NCT06444737 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron
Description: Intravenous (IV) ondansetron 0.10 mg/ kg diluted in 5 ml normal saline, 5 min before spinal anesthesia
Study NCT06444737 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Intravenous normal saline
Description: Intravenous normal saline 5 ml (control group) 5 min before spinal anesthesia
Study NCT04744831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-8201a 5.4 mg/kg Q3W
Description: DS-8201a for injection will be administered intravenously (IV) at a dose of 5.4 mg/kg every 3 weeks (Q3W)
Study NCT04744831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DS-8201a 6.4 mg/kg Q3W
Description: DS-8201a for injection will be administered intravenously (IV) at a dose of 6.4 mg/kg every 3 weeks (Q3W)
Study NCT06145711 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hiPSC-DAP
Description: Using hiPSC-DAP for the treatment of the patients of Parkinson's diease
Study NCT06454487 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric Hand Grip Training
Description: IHG training will be performed with an inflatable ball three days per week for 12 weeks (with at least a day of rest between each session) with intensity set based on RPE (Borg CR-10 scale).
Study NCT06454487 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CR
Description: Standard of Care
Study NCT06197802 — intervention group
Intervention type: BIOLOGICAL
Intervention: Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
Description: Three doses administered intramuscularly at 0, 45 day and 6 month.
Study NCT06197802 — intervention group
Intervention type: BIOLOGICAL
Intervention: Gardasil®9
Description: Three doses administered intramuscularly at 0, 45 day and 6 month.
Study NCT05535855 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD19 Directed CAR T Cell
Description: The UCD19 CAR T cells are developed through transfection of autologous peripheral blood mononuclear cells with a lentivirus carrying the DNA that encodes a short chain fragment variable region (scFv) derived from an anti-CD19 monoclonal antibody, among other elements.
Study NCT05411120 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Western Diet
Description: Western Diet is by high intakes of pre-packaged foods, refined grains, red meat, processed meat, high-sugar drinks, candy and sweets, fried foods, conventionally-raised animal products, butter and other high-fat dairy products, and low intakes of fruits, vegetables, whole grains.
Study NCT05411120 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CLEAN-MED
Description: Mediterranean like diet is a high consumption of vegetables, oil and moderate consumption of protein, with no processed foods.
Study NCT05626777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pre-filled syringe, mepolizumab 100 mg/month
Description: Pre-filled syringe, mepolizumab, 100 mg/month, 6 first months of treatment administered by nurse, 6 last months of treatment administered by patient
Study NCT05626777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Auto-injector pen, mepolizumab 100 mg/month
Description: Auto-injector pen, mepolizumab, 100 mg/month 12 months of treatment administered by patient
Study NCT05298046 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: TAVO101
Description: TAVO101 single ascending dose IV infusion.
Study NCT05298046 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Other: Placebo
Description: Placebo single ascending dose IV infusion.
Study NCT04775524 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Storytelling Through Music (STM)
Description: 6 week expressive arts-based program
Study NCT05621460 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 500mL carbonated water
Description: Drink 500mL carbonated water immediately prior to head-up tilt test
Study NCT04775524 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wait List / Storytelling Through Music-Hybrid
Description: 2 week song listening program
Study NCT04654052 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Clopidogrel
Description: Clopidogrel during 11 months
Study NCT04654052 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Previous treatment
Description: non-intervention
Study NCT06306976 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Elective Midline Laparotomy
Description: Patients with midline ventral incisional hernia with a range of hernia morphology who plan to undergo open retromuscular VHR.~Hernia repair:~All study patients will have an open retromuscular repair with/without additional lateral MFR (TAR or EOR at the discretion of the operating surgeon). All repairs beginning with retrorectus dissection to the level of the linea semilunaris.~All patients will have permanent mesh reinforcement of the abdominal wall (large-pore, midweight polypropylene). Fascia will be closed over the mesh with 0 or 2-0 polydioxanone slowly absorbable suture using a small-bite technique and a 4:1 suture length:wound length ratio.
Study NCT06306976 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Imaging: Ultrasound
Description: Ultrasound procedure will involve the following steps:~1. For control group 1 and group 2 patients, Images will be taken at two points along the bilateral RA; at the level of the umbilicus and midway between the umbilicus and xiphoid process. Bilateral external oblique (EO), internal oblique (IO), and transversus abdominis (TA) images will be performed at the level of the anterior axillary line midway between the costal margin and iliac crest.
Study NCT05621460 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 500mL still water
Description: Drink 500mL still water immediately prior to head-up tilt test
Study NCT06306976 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Tensiometry
Description: For all study patients, an analog spring-tensiometer will be used to assess intraoperative tension required to bring the fascia to the midline for closure. The tensiometer is attached to a clamp attached to the fascia at the midpoint of the hernia defect. Tension required for medialization to the midline will be performed after adhesiolysis (baseline), retrorectus dissetion, incision of the PLIO (if performed), and after completion of TAR or EOR (if performed).~Control group 2 patients will be undergoing first time laparotomy and will have tensiometry performed.
Study NCT06280560 — intervention group
Intervention type: PROCEDURE
Intervention: Controlled Ovarian Stimulation + Luteal Phase Support
Description: Short COS protocol with GnRH antagonist followed by progesterone supplementation. Will be initiated after a negative vaginal ultrasonographic scans to define ovarian quiescence, on days 1 and 2 of the menstrual period. For ovarian stimulation, 150-225 UI /day of FSHrec (GONAL F) will be administered along or in combination with 75 UI/day of HMG (Menopur). From day 6 onwards, HMG/FSHrec will be administered on an individual basis according to the serum E2 levels and transvaginal ovarian ultrasound scans and GnRH antagonist (Orgalutran) 0.25 mg /day is introduced as soon as a follicle of 14 mms diameter has achieved. hCGrec (6500 IU, Ovitrelle) will be administered when 7 or 8 follicles with a maximum diameter of >17-18 mms will observed. 400 mg of micronized vaginal progesterone will be administered (200 mg twice a day vaginal route), during 5 days. An endometrial biopsy and a blood sample will be obtained 7 days after hCG administration (hCH+7)
Study NCT06280560 — intervention group
Intervention type: PROCEDURE
Intervention: Hormonal Replacement Therapy programmed artificial cycle
Description: 6 mg of oestradiol orally administered starting the first day of the menstrual period, followed by an endometrial scan 10-days later, and when a 7 mms triple line endometrium has seen by vaginal ultrasound scan, 800 mg of micronized vaginal progesterone (400 mg twice a day vaginal route), during five days, will be added to the oestrogen therapy. An endometrial biopsy and a blood sample will be obtained on day 5 of progesterone administration (P+5)
Study NCT06280560 — intervention group
Intervention type: PROCEDURE
Intervention: Natural Cycle (NC)
Description: No hormonal stimulation. From day 6 of the menstrual period, follicular growth will be evaluated. As soon as a follicle reaches 17mm in diameter, ovulation test strips will be provided to assess LH levels in the first morning urine. The participant will report the positive and will be scheduled for sampling seven days later. An endometrial biopsy and a blood sample will be obtained 7 days after LH peak (LH+7)
Study NCT06280560 — intervention group
Intervention type: PROCEDURE
Intervention: Endometrial receptivity reference group
Description: Recruited among women belonging to the oocyte donation program and will follow the procedures described above for the Natural Cycle group. No hormonal stimulation. From day 6 of the menstrual period, follicular growth will be evaluated. As soon as a follicle reaches 17mm in diameter, ovulation test strips will be provided to assess LH levels in the first morning urine. The participant will report the positive and will be scheduled for sampling seven days later. An endometrial biopsy and a blood sample will be obtained 7 days after LH peak (LH+7)
Study NCT06015295 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 18F-Fluciclovine (Axumin)
Description: Given by Injection
Study NCT06015295 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pet Scan
Description: Scans
Study NCT06667856 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Asynchronous exercise group
Description: Application of foot core training combined with lower extremity exercises using asynchronous telerehabilitation method.
Study NCT06667856 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Synchronous exercise group
Description: Application of foot core training combined with lower extremity exercises using synchronous telerehabilitation method.
Study NCT04831164 — intervention group
Intervention type: OTHER
Intervention: NA (not an interventional study)
Description: (not an interventional study)
Study NCT06615271 — intervention group
Intervention type: PROCEDURE
Intervention: Neurosurgery
Description: Patients who have undergone neurosurgery form more than 3 hours.
Study NCT06615648 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PMT
Description: 7-minute PMT intervention video
Study NCT06615648 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Non-contact Control
Description: 6-minute alternative video
Study NCT04918108 — intervention group
Intervention type: BIOLOGICAL
Intervention: inflammatory response
Description: laboratory data (leukocyte, neutrophils, monocyte, lymphocytes, platelet, fibrinogen, D-dimer, neutrophils-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio)
Study NCT05322980 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Microcephaly
Description: Those with a z score of birth head circumference \< -2 (primary microcephaly) are classified into the Microcephaly group.
Study NCT06691971 — intervention group
Intervention type: DEVICE
Intervention: AeviceMD
Description: The AeviceMD device will be placed on the patient to detect the presence of wheeze and perform auscultation.